Any hereditary breast ovarian cancer syndrome in which the cause of the disease is a mutation in the BRCA2 gene.
Comprehensive, easy-to-understand information about this condition
How we create this content →The documentation for familial breast-ovarian cancer susceptibility type 2 is limited due to the rarity of the condition and the complexity of its genetic underpinnings. Since it affects a relatively small population, systematic clinical studies have been sparse. Furthermore, the genetic basis is still being explored, which complicates the characterization of clinical features. This situation can be frustrating, but ongoing research may provide more insights in the future.
To navigate your condition effectively, consider seeking a genetic counselor who specializes in hereditary cancer syndromes. They can provide insights into genetic testing options for you and your family, which is crucial given the autosomal dominant inheritance pattern. Additionally, exploring clinical trials may offer opportunities for participation in research that could lead to new treatment options. For resources, visit the National Society of Genetic Counselors at findageneticcounselor.com for a directory of professionals. Engaging with clinical trials can also provide valuable information about the condition and potential interventions.
Currently, there is one active clinical trial related to familial breast-ovarian cancer susceptibility type 2. This trial aims to explore potential treatment options and gather more data on the condition. For more information on this trial, you can visit ClinicalTrials.gov and search for 'breast-ovarian cancer, familial, susceptibility to, 2'. While no orphan drugs have been designated for this condition, participation in clinical trials may provide access to cutting-edge treatments and contribute to the understanding of this rare disease.
Actionable guidance for navigating care for breast-ovarian cancer, familial, susceptibility to, 2
To navigate your condition effectively, consider seeking a genetic counselor who specializes in hereditary cancer syndromes. They can provide insights into genetic testing options for you and your family, which is crucial given the autosomal dominant inheritance pattern. Additionally, exploring clinical trials may offer opportunities for participation in research that could lead to new treatment options. For resources, visit the National Society of Genetic Counselors at findageneticcounselor.com for a directory of professionals. Engaging with clinical trials can also provide valuable information about the condition and potential interventions.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation for familial breast-ovarian cancer susceptibility type 2 is limited due to the rarity of the condition and the complexity of its genetic underpinnings. Since it affects a relatively small population, systematic clinical studies have been sparse. Furthermore, the genetic basis is still being explored, which complicates the characterization of clinical features. This situation can be frustrating, but ongoing research may provide more insights in the future.
To navigate your condition effectively, consider seeking a genetic counselor who specializes in hereditary cancer syndromes. They can provide insights into genetic testing options for you and your family, which is crucial given the autosomal dominant inheritance pattern. Additionally, exploring clinical trials may offer opportunities for participation in research that could lead to new treatment options. For resources, visit the National Society of Genetic Counselors at findageneticcounselor.com for a directory of professionals. Engaging with clinical trials can also provide valuable information about the condition and potential interventions.
Currently, there is one active clinical trial related to familial breast-ovarian cancer susceptibility type 2. This trial aims to explore potential treatment options and gather more data on the condition. For more information on this trial, you can visit ClinicalTrials.gov and search for 'breast-ovarian cancer, familial, susceptibility to, 2'. While no orphan drugs have been designated for this condition, participation in clinical trials may provide access to cutting-edge treatments and contribute to the understanding of this rare disease.
Actionable guidance for navigating care for breast-ovarian cancer, familial, susceptibility to, 2
To navigate your condition effectively, consider seeking a genetic counselor who specializes in hereditary cancer syndromes. They can provide insights into genetic testing options for you and your family, which is crucial given the autosomal dominant inheritance pattern. Additionally, exploring clinical trials may offer opportunities for participation in research that could lead to new treatment options. For resources, visit the National Society of Genetic Counselors at findageneticcounselor.com for a directory of professionals. Engaging with clinical trials can also provide valuable information about the condition and potential interventions.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation for familial breast-ovarian cancer susceptibility type 2 is limited due to the rarity of the condition and the complexity of its genetic underpinnings. Since it affects a relatively small population, systematic clinical studies have been sparse. Furthermore, the genetic basis is still being explored, which complicates the characterization of clinical features. This situation can be frustrating, but ongoing research may provide more insights in the future.
To navigate your condition effectively, consider seeking a genetic counselor who specializes in hereditary cancer syndromes. They can provide insights into genetic testing options for you and your family, which is crucial given the autosomal dominant inheritance pattern. Additionally, exploring clinical trials may offer opportunities for participation in research that could lead to new treatment options. For resources, visit the National Society of Genetic Counselors at findageneticcounselor.com for a directory of professionals. Engaging with clinical trials can also provide valuable information about the condition and potential interventions.
Currently, there is one active clinical trial related to familial breast-ovarian cancer susceptibility type 2. This trial aims to explore potential treatment options and gather more data on the condition. For more information on this trial, you can visit ClinicalTrials.gov and search for 'breast-ovarian cancer, familial, susceptibility to, 2'. While no orphan drugs have been designated for this condition, participation in clinical trials may provide access to cutting-edge treatments and contribute to the understanding of this rare disease.
Actionable guidance for navigating care for breast-ovarian cancer, familial, susceptibility to, 2
To navigate your condition effectively, consider seeking a genetic counselor who specializes in hereditary cancer syndromes. They can provide insights into genetic testing options for you and your family, which is crucial given the autosomal dominant inheritance pattern. Additionally, exploring clinical trials may offer opportunities for participation in research that could lead to new treatment options. For resources, visit the National Society of Genetic Counselors at findageneticcounselor.com for a directory of professionals. Engaging with clinical trials can also provide valuable information about the condition and potential interventions.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.